Medtronic MDT
NYSE MDT
$102.33 +0.53 (+0.52%)
As of: Nov 9, 2026 · 10:05 AM EST

Medtronic (MDT) Gains from Sales and Divestitures (2017)

Updated

Medtronic's Gains from Sales and Divestitures was $697 million in FY2018 (year ended Apr 27, 2018).

Analysis

Medtronic (MDT) Gains from Sales and Divestitures (2017) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 258.81 Bn 235.32 Bn 5.13 Bn
2 Abbott Laboratories 189.40 Bn 163.27 Bn 7.39 Bn
3 Danaher 162.08 Bn 141.74 Bn 3.84 Bn
4 Intuitive Surgical 158.99 Bn 139.28 Bn 2.08 Bn
5 Medtronic 130.53 Bn 95.78 Bn 6.34 Bn
6 Stryker 124.82 Bn 111.01 Bn 4.25 Bn
7 Boston Scientific 62.97 Bn 58.41 Bn 3.43 Bn
8 Edwards Lifesciences 59.51 Bn 42.71 Bn 1.35 Bn
9 Becton Dickinson 58.44 Bn 55.59 Bn 2.32 Bn
10 Agilent Technologies 49.83 Bn 42.72 Bn 1.04 Bn
Historic Data

Historic Data

Download Data
DateValue
Oct 27, 2017 697.00 Mn
API Access

Medtronic Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=MDT&period=max&api_key=YOUR_API_KEY